Therapeutic Potentials of Curcumin for Alzheimer Disease

Mehr zum Buch

This book is the first to delve into the significance of curcumin in treating neurological disorders. With an estimated 35.6 million people affected by dementia globally in 2010, projections suggest this number could double every 20 years, potentially reaching 115.4 million by 2050. Alzheimer’s disease (AD), the primary cause of dementia, affects 60%–70% of those with the condition. Without breakthroughs in prevention or treatment, cases in the US alone may triple to 13.2 million by 2050. Therefore, exploring curcumin's role in delaying and treating AD is crucial. A healthy diet rich in curcumin, along with moderate exercise and adequate sleep, may enhance motor and cognitive functions, as well as address memory deficits associated with aging and AD. Regular curcumin consumption could alleviate some healthcare burdens by delaying AD's onset and progression. This volume offers a comprehensive and contemporary examination of curcumin's therapeutic potential in AD, based on cell culture and animal model research. It serves as a valuable resource for students, educators, researchers, dietitians, nutritionists, and physicians, and can supplement various neuroscience and nutrition courses. Clinicians, neuroscientists, neurologists, and pharmacologists will benefit from insights into the molecular mechanisms of curcumin in AD treatment.